Phase II study on weekly bolus topotecan in advanced or recurrent cervical cancer

Domenica Lorusso, Giovanni Scambia, Sara Mainenti, Antonella Pietragalla, Paola Malaguti, Valeria Masciullo, E Fusco

Risultato della ricerca: Contributo in rivistaArticolo in rivista

2 Citazioni (Scopus)

Abstract

It was the aim of our study to evaluate the efficacy and safety of weekly topotecan in patients with advanced or recurrent cervical disease.
Lingua originaleEnglish
pagine (da-a)390-394
Numero di pagine5
RivistaOncology
Volume80
DOI
Stato di pubblicazionePubblicato - 2011

Keywords

  • Adenocarcinoma
  • Adult
  • Aged
  • Antineoplastic Agents
  • Carcinoma, Squamous Cell
  • Drug Administration Schedule
  • Female
  • Humans
  • Infusions, Intravenous
  • Injections, Intravenous
  • Middle Aged
  • Neoplasm Recurrence, Local
  • Neoplasm Staging
  • Topoisomerase I Inhibitors
  • Topotecan
  • Treatment Failure
  • Uterine Cervical Neoplasms

Fingerprint

Entra nei temi di ricerca di 'Phase II study on weekly bolus topotecan in advanced or recurrent cervical cancer'. Insieme formano una fingerprint unica.

Cita questo